- Home
- / AZTherapies
AZTherapies
Total Funding
$97.7 M
AZTherapies Summary
Company Summary
- Overview
- AZTherapies is a developer of pharmaceutical drugs designed to provide treatment for multiple neurodegenerations and neuroinflammation-related CNS diseases. Its product ALZT-OP1 is a novel multi-action combination drug regimen that is used to modify disease progression by slowing down or halting Alzheimer's disease early in its development.
- Type
- Private
- Status
- Active
- Founded
- 2011
- HQ
- Boston, MA, US | view all locations
- Website
- https://aztherapies.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Boston, MA HQ
United States
John Hancock Tower, 200 Clarendon St 17th Floor
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2024